Keyphrases
Lentiviral Vector
100%
Small Interfering RNA (siRNA)
69%
Short Hairpin RNA (shRNA)
56%
Gene Therapy
49%
Ribozyme
47%
Human Immunodeficiency Virus Type 1 (HIV-1)
41%
Decoy
36%
T Cells
35%
C-C Chemokine Receptor Type 5 (CCR5)
32%
Hematopoietic Cells
27%
Recombination
25%
Anti-HIV
25%
Vector Delivery
22%
Macrophages
19%
B Cells
19%
CD34+ Stem Cells
18%
RNA-based
17%
AIDS/HIV
17%
Hematopoietic Stem Cells
17%
DNA Damage
15%
Neurological Disorders
15%
RAD51
15%
HIV-1 Infection
15%
Switch Region
15%
Virus Gene
15%
RNA Interference
13%
RNA Decoy
12%
CD34+
12%
CD34+ Cells
12%
Gene Delivery
11%
Nucleolar
11%
Cell-based
11%
SCID Mice
10%
Class Switch Recombination
10%
Human Cells
10%
HIV-1 Rev
10%
Gene Expression
9%
Pol III
9%
Triple Combination
9%
Recombination Activity
9%
Pol II
9%
Cell-derived
9%
Pol III Promoter
9%
Interferon Response
8%
Inducible Expression
8%
Long-range Inhibition
8%
Non-dividing Cells
8%
Viral Vectors
8%
Transgene Expression
8%
Central Nervous System
8%
Biochemistry, Genetics and Molecular Biology
Lentivirus Vector
71%
Small Hairpin RNA
55%
Human Immunodeficiency Virus
54%
Small Interfering RNA
51%
Human Immunodeficiency Virus 1
44%
Gene Therapy
40%
Ribozyme
39%
RNA
37%
Promoter Region
28%
CCR5
25%
CD34
22%
Hematopoietic Stem Cell
16%
B Cell
15%
Virus Gene
15%
Mouse
14%
T Cell
12%
RNA Interference
12%
Gene Targeting
11%
Mammalian Cell
10%
Stem Cell
9%
Stable Expression
9%
Cell Cycle
8%
Interferon
8%
interferon
8%
Titer
8%
Expression Cassette
8%
Transgene
8%
DNA Damage Response
8%
Nucleolin
7%
DNA Repair
7%
Progenitor Cell
7%
Cytosine
7%
Gene Promoter
7%
DNA Damage
7%
Transcription Factors
7%
Methylation
7%
Apolipoprotein
7%
Myeloid
7%
Calreticulin
7%
HNRPD
7%
Amyloid
7%
Adeno Associated Virus
7%
Quality Control
7%
Proteasome Inhibitor
7%
Calnexin
7%
Binding Protein
7%
Product Inhibition
7%
Cell Activation
7%
Mouse Model
7%
Transactivation
7%
Immunology and Microbiology
Lentivirus Vector
55%
Human Immunodeficiency Virus
51%
Human Immunodeficiency Virus 1
47%
CD34
40%
T Cell
39%
CCR5
34%
B Cell
26%
Macrophage
25%
Hematopoietic Cell
22%
Hematopoietic Stem Cell
22%
Mouse
22%
Promoter Region
16%
Human Immunodeficiency Virus Infection
14%
Cell Line
12%
Stem Cell
12%
RNA Interference
10%
Cell Cycle
9%
DNA Damage
8%
HIV/AIDS
8%
Stable Expression
8%
DNA Damage Response
8%
Immunoglobulin Heavy Chain
8%
Saimiriine Herpesvirus 2
7%
Titer
7%
Epstein Barr Virus
7%
DNA Repair
7%
Intravenous Immunoglobulin
7%
T Cell Activation
7%
Transactivation
7%
Severe Combined Immunodeficiency
7%
B Cell Activation
7%
Virus Gene
7%
interferon
7%
Spine
6%
Transgene
6%
Monospecific Antibody
5%
Genetic Transduction
5%